C2P Forum proudly presents the 2nd European Congress on Rare Diseases and Orphan Drugs, set to take place on September 14-15, 2026 in London, UK. This two-day event uniting researchers, clinicians, industry leaders, policymakers, and patient advocates from across the globe.
This congress will provide a dynamic platform to explore the latest innovations, challenges, and breakthroughs in rare disease research and orphan drug development. With the aim of fostering collaboration, raising awareness, and accelerating progress, the event will highlight real-world solutions to improve the lives of those affected by rare diseases.
The program will feature keynote lectures, plenary sessions, panel discussions, interactive workshops, and networking opportunities, along with an exhibition showcasing emerging technologies and therapies.